Cargando…

The Role of Age on Beta-Amyloid(1–42) Plasma Levels in Healthy Subjects

Beta-amyloid (Aβ) plaques have been observed in the brain of healthy elderlies with frequencies strongly influenced by age. The aim of the study is to evaluate the role of age and other biochemical and hematological parameters on Aβ(1–42) plasma levels in cognitively and neurologically normal indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zecca, Chiara, Pasculli, Giuseppe, Tortelli, Rosanna, Dell’Abate, Maria Teresa, Capozzo, Rosa, Barulli, Maria Rosaria, Barone, Roberta, Accogli, Miriam, Arima, Serena, Pollice, Alessio, Brescia, Vincenzo, Logroscino, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438760/ https://www.ncbi.nlm.nih.gov/pubmed/34531734 http://dx.doi.org/10.3389/fnagi.2021.698571

Ejemplares similares

Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis
por: Zecca, Chiara, et al.
Publicado: (2022)

Plasma Inflammatory Cytokines Are Elevated in ALS
por: Tortelli, Rosanna, et al.
Publicado: (2020)

A New Presenilin 1 (Psen1) Mutation (p.Cys263Trp) as a Cause of Both Early and Late-Onset Alzheimer’s Disease in a Large Italian Family
por: Tortelli, Rosanna, et al.
Publicado: (2021)

Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
por: Bramato, Giulia, et al.
Publicado: (2022)

The Italian Version of the Test Your Memory (TYM-I): A Tool to Detect Mild Cognitive Impairment in the Clinical Setting
por: Barulli, Maria Rosaria, et al.
Publicado: (2021)

Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study
por: Barulli, Maria Rosaria, et al.
Publicado: (2015)

FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective
por: Pignataro, Patrizia, et al.
Publicado: (2021)

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay
por: Malerba, Francesca, et al.
Publicado: (2021)

The Relationship Between Muscle Strength and Cognitive Performance Across Alzheimer's Disease Clinical Continuum
por: Filardi, Marco, et al.
Publicado: (2022)

Brain Structural Covariance Networks in Behavioral Variant of Frontotemporal Dementia
por: Nigro, Salvatore, et al.
Publicado: (2021)

The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas
por: Logroscino, Giancarlo, et al.
Publicado: (2022)

Neuroimaging Findings in a Patient with Anti-IgLON5 Disease: Cerebrospinal Fluid Dynamics Abnormalities
por: Urso, Daniele, et al.
Publicado: (2022)

Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: a case report
por: Battista, Petronilla, et al.
Publicado: (2019)

Reduction of Sniff Nasal Inspiratory Pressure (SNIP) as an Early Indicator of the Need of Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis
por: Zoccolella, Stefano, et al.
Publicado: (2021)

Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
por: Panza, Francesco, et al.
Publicado: (2016)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

AFM Probing of Amyloid-Beta 42 Dimers and Trimers
por: Maity, Sibaprasad, et al.
Publicado: (2020)

COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis
por: Palmer, Suetonia C, et al.
Publicado: (2015)

Exploring dementia and neuronal ceroid lipofuscinosis genes in 100 FTD-like patients from 6 towns and rural villages on the Adriatic Sea cost of Apulia
por: Sassi, Celeste, et al.
Publicado: (2021)

Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
por: Gericke, Christoph, et al.
Publicado: (2020)

Amyloid-beta 42 adsorption following serial tube transfer
por: Toombs, Jamie, et al.
Publicado: (2014)

Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice
por: Pignataro, Patrizia, et al.
Publicado: (2023)

Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice
por: Dicarlo, Manuela, et al.
Publicado: (2023)

Treatment of postoperative accessory bile duct injury by fibrin glue and balloon tamponade: a case report
por: Bonati, Elena, et al.
Publicado: (2019)

Intestinal duplications: incidentally ileum duplication cyst in young female
por: Martini, Chiara, et al.
Publicado: (2019)

Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42
por: Zaretsky, Dmitry V., et al.
Publicado: (2022)

Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy
por: de Kort, Anna M., et al.
Publicado: (2023)

Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
por: Sinclair, Patricia, et al.
Publicado: (2021)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

Classification of Single Normal and Alzheimer's Disease Individuals from Cortical Sources of Resting State EEG Rhythms
por: Babiloni, Claudio, et al.
Publicado: (2016)

Prefrontal Activity and Connectivity with the Basal Ganglia during Performance of Complex Cognitive Tasks Is Associated with Apathy in Healthy Subjects
por: Fazio, Leonardo, et al.
Publicado: (2016)

Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, β(1–42)-Amyloid or the β(1–42)-Amyloid Aluminum Complex
por: Gatta, Valentina, et al.
Publicado: (2011)

Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
por: Mezzapesa, Domenico Maria, et al.
Publicado: (2013)

Age-related hearing impairment and frailty in Alzheimer's disease: interconnected associations and mechanisms
por: Panza, Francesco, et al.
Publicado: (2015)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
por: Ring, Julia, et al.
Publicado: (2022)

Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study
por: Wiest, Reiner, et al.
Publicado: (2021)

Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017)

Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
por: Vojdani, Aristo, et al.
Publicado: (2018)

Nasal mucosal inhalation of amyloid-beta peptide 3–10 defective adenovirus attenuates cytotoxicity induced by beta-amyloid (1–42)
por: Jiang, Tongzi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fqe5mrlftnja91ru7kg616g9i3